Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer.

doi:10.1038/s41397-017-0009-x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer.

The pharmacogenomics journal - 1 Jul 2018

Riera Pau, Virgili Anna C, Salazar Juliana, Sebio Ana, Tobeña María, Sullivan Ivana, Páez David

Abstract excerpt

The role of vascular endothelial growth factor (VEGF) gene polymorphisms in the prognosis of colon cancer prognosis remains unclear. We evaluated the influence of 28 single-nucleotide polymorphisms in 12 genes in the VEGF pathway on the prognosis of 347 patients with stage II-III colon cancer. We found that rs9513070 (VEGFR1) and rs1137282 (KRAS) were associated with overall survival in stage II colon cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged

Share to Colonic Neoplasms

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Prognosis

Share to Progression-Free Survival

Share to Proto-Oncogene Proteins p21(ras)

Share to Vascular Endothelial Growth Factor Receptor-1

Source

Open in PubMed

Identifiers

PMID: 29282362
DOI: 10.1038/s41397-017-0009-x

Genes

ITGAV
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer.PMID 29282362Read ↗

Prognostic importance of VEGF-A haplotype combinations in a stage II colon cancer population.Semantic proximity Read ↗

The association of VEGF rs833061 and rs2010963 polymorphisms with susceptibility to colorectal cancer in an Iranian population.Semantic proximity Read ↗

Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer.Semantic proximity Read ↗

Investigation of Vascular Endothelial Growth Factor Polymorphisms on Risk, Metastasis, Laterality, and Prognosis of Colorectal Cancer in Turkish Subjects.Semantic proximity Read ↗

Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival.Semantic proximity Read ↗

Vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.Semantic proximity Read ↗

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patientsSemantic proximity Read ↗

Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.Semantic proximity Read ↗

VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.Semantic proximity Read ↗

Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis.Semantic proximity Read ↗

Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapySemantic proximity Read ↗

Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.